Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Clinical trial NCT06232551 · UNKNOWN

Trial details

NCT number: NCT06232551
Sponsor: Scott C. Woller, MD
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Venous Thromboembolic Disease Pulmonary Embolism and Thrombosis Deep Vein Thrombosis Hospitalism

Start date: 2024-06-01
Primary completion: 2025-01-15
Enrollment: 152000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.